Search research articles
Contact Us
Filters
Showing results (741-750 of 796) with videos related to
Page
of 80
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
October 21, 2023
Digital behavioural signatures reveal trans-diagnostic clusters of Schizophrenia and Alzheimer's disease patients
Martien J H Kas, Niels Jongs, Maarten Mennes, et al.
Translational Psychiatry
|
December 12, 2013
The effects of ketamine and risperidone on eye movement control in healthy volunteers
A Schmechtig, J Lees, A Perkins, et al.
Bjpsych Open
|
April 13, 2026
The cost-effectiveness of predictive algorithm guided primary antidepressant treatment: economic evaluation of the multinational PReDicT randomised controlled trial
Nataša Perić, Susanne Mayer, Timea Helter, et al.
ACS Nano
|
September 6, 2019
Intracellular Photothermal Delivery for Suspension Cells Using Sharp Nanoscale Tips in Microwells
Tianxing Man, Xiongfeng Zhu, Yu Ting Chow, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 27, 2005
TPA023 [7-(1,1-dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine], an agonist selective for alpha2- and alpha3-containing GABAA receptors, is a nonsedating anxiolytic in rodents and primates
John R Atack, Keith A Wafford, Spencer J Tye, et al.
Genetics
|
July 18, 2018
A Genome-Wide Screen Reveals a Role for the HIR Histone Chaperone Complex in Preventing Mislocalization of Budding Yeast CENP-A
Sultan Ciftci-Yilmaz, Wei-Chun Au, Prashant K Mishra, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
September 7, 2022
Theory of Mind and social functioning among neuropsychiatric disorders: A transdiagnostic study
S Braak, T Su, W Krudop, et al.
Journal of Psychopharmacology (Oxford, England)
|
February 12, 2010
MRK-409 (MK-0343), a GABAA receptor subtype-selective partial agonist, is a non-sedating anxiolytic in preclinical species but causes sedation in humans
J R Atack, K A Wafford, L J Street, et al.
Journal of Medicinal Chemistry
|
March 19, 2004
3-phenyl-6-(2-pyridyl)methyloxy-1,2,4-triazolo[3,4-a]phthalazines and analogues: high-affinity gamma-aminobutyric acid-A benzodiazepine receptor ligands with alpha 2, alpha 3, and alpha 5-subtype binding selectivity over alpha 1
Robert W Carling, Kevin W Moore, Leslie J Street, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 6, 2005
An inverse agonist selective for alpha5 subunit-containing GABAA receptors enhances cognition
G R Dawson, K A Maubach, N Collinson, et al.
Page
of 80
Search research articles
Search
Showing results (741-750 of 796) with videos related to
Sort By:
Page
of 80
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
October 21, 2023
Digital behavioural signatures reveal trans-diagnostic clusters of Schizophrenia and Alzheimer's disease patients
Martien J H Kas, Niels Jongs, Maarten Mennes, et al.
Translational Psychiatry
|
December 12, 2013
The effects of ketamine and risperidone on eye movement control in healthy volunteers
A Schmechtig, J Lees, A Perkins, et al.
Bjpsych Open
|
April 13, 2026
The cost-effectiveness of predictive algorithm guided primary antidepressant treatment: economic evaluation of the multinational PReDicT randomised controlled trial
Nataša Perić, Susanne Mayer, Timea Helter, et al.
ACS Nano
|
September 6, 2019
Intracellular Photothermal Delivery for Suspension Cells Using Sharp Nanoscale Tips in Microwells
Tianxing Man, Xiongfeng Zhu, Yu Ting Chow, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 27, 2005
TPA023 [7-(1,1-dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine], an agonist selective for alpha2- and alpha3-containing GABAA receptors, is a nonsedating anxiolytic in rodents and primates
John R Atack, Keith A Wafford, Spencer J Tye, et al.
Genetics
|
July 18, 2018
A Genome-Wide Screen Reveals a Role for the HIR Histone Chaperone Complex in Preventing Mislocalization of Budding Yeast CENP-A
Sultan Ciftci-Yilmaz, Wei-Chun Au, Prashant K Mishra, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
September 7, 2022
Theory of Mind and social functioning among neuropsychiatric disorders: A transdiagnostic study
S Braak, T Su, W Krudop, et al.
Journal of Psychopharmacology (Oxford, England)
|
February 12, 2010
MRK-409 (MK-0343), a GABAA receptor subtype-selective partial agonist, is a non-sedating anxiolytic in preclinical species but causes sedation in humans
J R Atack, K A Wafford, L J Street, et al.
Journal of Medicinal Chemistry
|
March 19, 2004
3-phenyl-6-(2-pyridyl)methyloxy-1,2,4-triazolo[3,4-a]phthalazines and analogues: high-affinity gamma-aminobutyric acid-A benzodiazepine receptor ligands with alpha 2, alpha 3, and alpha 5-subtype binding selectivity over alpha 1
Robert W Carling, Kevin W Moore, Leslie J Street, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 6, 2005
An inverse agonist selective for alpha5 subunit-containing GABAA receptors enhances cognition
G R Dawson, K A Maubach, N Collinson, et al.
Page
of 80